Yushi Qiu

Pomalidomide Shows Significant Therapeutic Activity against CNS Lymphoma with a Major Impact on the Tumor Microenvironment in Murine Models

Zhimin Li, Yushi Qiu, David Personett et al. · PLoS ONE · 2013 · 97 citations · Full text

Medicine, Oncology, Pharmacology +17

Pomalidomide Alters Pancreatic Macrophage Populations to Generate an Immune-Responsive Environment at Precancerous and Cancerous Lesions

Ligia I. Bastea, Geou‐Yarh Liou, Veethika Pandey et al. · Cancer Research · 2019 · 31 citations · Full text

Medicine, Immunology, Oncology +17

Osteopontin is a multi-faceted pro-tumorigenic driver for central nervous system lymphoma

Yushi Qiu, Zhimin Li, Christina A. Von Roemeling et al. · Oncotarget · 2016 · 26 citations · Full text

Medicine, Cancer Biology, Oncology +14

An integrated approach to the discovery of potent agelastatin A analogues for brain tumors: chemical synthesis and biological, physicochemical and CNS pharmacokinetic analyses

Zhimin Li, Daisuke Shigeoka, Thomas R. Caulfield et al. · MedChemComm · 2013 · 21 citations

Pharmacy, Medicinal Chemistry, Pharmacology +17

LRRTM3 Interacts with APP and BACE1 and Has Variants Associating with Late-Onset Alzheimer’s Disease (LOAD)

Sarah Lincoln, Mariet Allen, Claire Cox et al. · PLoS ONE · 2013 · 17 citations · Full text

Life Sciences, Molecular Biology, Neuroscience +12